临床怀疑与毒理学发现不符:巴西急诊精神活性物质中毒证据(2023-2024)
结果显示临床怀疑与确认物质一致性低,可卡因和大麻是最常被怀疑和确认的非法物质,苯二氮䓬类、抗抑郁药和抗精神病药很少被怀疑但常被检出。多物质暴露高度普遍,每例中位检出四种物质。严重或致命病例与检出物质数量显著更多及患者年龄较大相关。结论认为仅凭临床怀疑不足以准确识别精神活性物质,应将全面毒理学检测整合入常规临床实践。
要点
- 临床怀疑与毒理学确认的物质一致性低,苯二氮䓬类、抗抑郁药和抗精神病药很少被怀疑但常被检出。
- 多物质暴露高度普遍,每例中位检出四种物质,严重或致命病例与检出物质数量显著更多相关。
- 严重或致命病例与患者年龄较大显著相关;致命病例罕见但均涉及甲醇和阿片类等高危物质。
- 神经系统和心血管症状为主,癫痫发作与兴奋剂强相关,呼吸抑制与镇静剂和阿片类组合相关。
- 仅凭症状评估不足以评估精神活性物质急性中毒,常规整合全面毒理学检测可提高诊断信心。
适用人群与场景
- 排除无生物样本或毒理学请求与精神活性物质无关的病例。
- 场景为毒物控制中心急诊病例,临床和人口学数据来自DATATOX国家数据库。
诊断标准与关键阈值
- 临床严重程度采用Poison Severity Score分类。
- 毒理学确认通过色谱和质谱技术检测血液和尿液样本。
- 原文未提及具体评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 致命病例均涉及甲醇和阿片类等高危物质。
- 癫痫发作与兴奋剂强相关,呼吸抑制与镇静剂和阿片类组合相关。
- 严重或致命病例与检出物质数量显著更多及患者年龄较大相关。
研究设计与关键结果
- 横断面观察研究,纳入385例疑似精神活性物质中毒病例,单国两中心(毒物控制中心和分析毒理学实验室)。
- 临床怀疑与毒理学确认一致性低;可卡因和大麻是最常被怀疑和确认的非法物质。
- 苯二氮䓬类、抗抑郁药和抗精神病药很少被怀疑但常被检出。
- 多物质暴露高度普遍,每例中位检出四种物质。
- 严重或致命病例与检出物质数量显著更多及患者年龄较大相关;致命病例罕见但均涉及甲醇和阿片类等高危物质。
- 神经系统和心血管症状为主,癫痫发作与兴奋剂强相关,呼吸抑制与镇静剂和阿片类组合相关。
证据类型、等级与局限
- 证据类型:横断面观察研究。
- 局限:单国两中心、观察性设计、样本量385例;原文未提及其他局限。
对床旁实践的改变
- 仅凭临床怀疑不足以准确识别精神活性物质,苯二氮䓬类和治疗药物常被漏识。
- 建议将全面毒理学检测整合入常规临床实践,以提高诊断信心和识别未怀疑的共暴露。
- 多物质暴露普遍,严重病例与检出物质数量更多相关,评估时应考虑多种物质共存。
- 适用与不适用人群:原文仅纳入疑似精神活性物质中毒病例,排除无生物样本或毒理学请求无关者;其他人群未提及。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The emergence of new psychoactive substances and adulteration of illicit drugs complicate acute poisoning diagnosis. This study evaluated concordance between clinical suspicion and toxicological confirmation and factors associated with poisoning severity.
METHODS: This cross-sectional observational study was conducted at the Poison Control Center of Campinas University and the analytical toxicology laboratory, Campinas, Brazil, between January 2023 and December 2024. A total of 385 cases of suspected psychoactive substance poisoning were included. Cases without biological samples or with toxicological requests unrelated to psychoactive substances were excluded. Clinical and demographic data were extracted from the DATATOX national database, and blood and urine toxicological results were obtained by chromatographic and mass spectrometric techniques. Concordance between clinical suspicion and toxicological confirmation, and associations with demographic and toxicological variables were assessed. Clinical severity was classified by the Poison Severity Score.
RESULTS: Concordance between suspected and confirmed substances was low. Cocaine and cannabis were the most frequently suspected and confirmed illicit substances, while benzodiazepines, antidepressants, and antipsychotics were rarely suspected but frequently detected. Polysubstance exposures were highly prevalent, with a median of four substances per case. Severe or fatal cases were associated with a significantly higher number of detected substances and with older patient age. Fatalities were rare but consistently involved high-risk agents such as methanol and opioids. Neurological and cardiovascular symptoms predominated, with seizures strongly associated with stimulants and respiratory depression with sedative and opioid combinations.
DISCUSSION: The substantial discrepancy between clinical suspicion and laboratory confirmation demonstrates that symptom-based assessment alone is insufficient for the evaluation of acute poisonings involving psychoactive substances. The routine integration of comprehensive toxicological testing may improve diagnostic confidence, facilitate the identification of unsuspected co-exposures, and enhance both patient management and toxicovigilance.
CONCLUSION: Clinical suspicion alone is insufficient for accurate identification of psychoactive substances in acute poisonings. Comprehensive toxicological testing revealed frequent under recognition of benzodiazepines and therapeutic drugs, and a high prevalence of polysubstance use. Integration of laboratory confirmation into routine clinical practice is essential to improve patient care, inform toxicovigilance, and improve international surveillance of psychoactive substance use.
参考来源
- Bueno Faria Dos Santos NC, Lanaro R, Soubhia PC, et al. Clinical suspicion versus toxicological findings in psychoactive substance poisonings: evidence from emergency cases in Brazil (2023-2024). Clin Toxicol (Phila). 2026. PMID: 42657527. doi:10.1080/15563650.2026.2714934
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。